Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 2
2006 1
2007 2
2008 1
2009 3
2011 2
2012 1
2013 4
2014 5
2015 2
2016 4
2017 4
2018 6
2019 6
2020 5
2021 6
2022 7
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis.
Ebina K, Tsuboi H, Nagayama Y, Kashii M, Kaneshiro S, Miyama A, Nakaya H, Kunugiza Y, Hirao M, Okamura G, Etani Y, Takami K, Goshima A, Miura T, Nakata K, Okada S. Ebina K, et al. Among authors: tsuboi h. Joint Bone Spine. 2021 Oct;88(5):105219. doi: 10.1016/j.jbspin.2021.105219. Epub 2021 May 19. Joint Bone Spine. 2021. PMID: 34020048
Reply to letter to the editor by Yoshii.
Nagayama Y, Ebina K, Tsuboi H, Hirao M, Hashimoto J, Yoshikawa H, Okada S, Nakata K. Nagayama Y, et al. Among authors: tsuboi h. J Orthop Sci. 2023 May;28(3):717-718. doi: 10.1016/j.jos.2023.02.023. Epub 2023 Mar 10. J Orthop Sci. 2023. PMID: 36907777 No abstract available.
Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis.
Ebina K, Etani Y, Tsuboi H, Nagayama Y, Kashii M, Miyama A, Kunugiza Y, Hirao M, Okamura G, Noguchi T, Takami K, Goshima A, Miura T, Fukuda Y, Kurihara T, Okada S, Nakata K. Ebina K, et al. Among authors: tsuboi h. Osteoporos Int. 2022 Nov;33(11):2441-2443. doi: 10.1007/s00198-022-06545-1. Epub 2022 Sep 6. Osteoporos Int. 2022. PMID: 36066579 No abstract available.
Modified Anterolateral Approach for Total Ankle Arthroplasty.
Hirao M, Ebina K, Etani Y, Kaneshiro S, Tsuboi H, Noguchi T, Okamura G, Kunugiza Y, Nakaya H, Nishikawa M, Tsuji S, Takahi K, Owaki H, Hashimoto J. Hirao M, et al. Among authors: tsuboi h. Foot Ankle Orthop. 2021 Jun 21;6(2):24730114211013342. doi: 10.1177/24730114211013342. eCollection 2021 Apr. Foot Ankle Orthop. 2021. PMID: 35097449 Free PMC article.
An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case-control study.
Ebina K, Nagayama Y, Kashii M, Tsuboi H, Okamura G, Miyama A, Etani Y, Noguchi T, Hirao M, Miura T, Fukuda Y, Kurihara T, Nakata K, Okada S. Ebina K, et al. Among authors: tsuboi h. Osteoporos Int. 2024 May;35(5):841-849. doi: 10.1007/s00198-024-07019-2. Epub 2024 Jan 31. Osteoporos Int. 2024. PMID: 38296866
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).
Misaki K, Tamura N, Azuma T, Shinoda K, Tanaka M, Fujiwara H, Tsuboi H, Kasama T, Yoshimi R, Hanyu T, Kusaka Y, Hirao M, Onishi M, Uchino A, Izumiyama T, Yang KS, Ogawa N, Matsui K, Kurasawa K, Kawaai S, Yasuoka H, Okumura N, Ueda Y, Tanaka E, Inoue E, Tsuritani K, Matsumoto S, Yamanaka H, Harigai M. Misaki K, et al. Among authors: tsuboi h. Mod Rheumatol. 2024 Feb 26;34(2):297-306. doi: 10.1093/mr/road045. Mod Rheumatol. 2024. PMID: 37233722
61 results